PORCIANI, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.632
EU - Europa 1.833
AS - Asia 333
OC - Oceania 25
AF - Africa 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.835
Nazione #
US - Stati Uniti d'America 2.631
RU - Federazione Russa 590
PL - Polonia 526
SE - Svezia 178
IE - Irlanda 168
IT - Italia 116
HK - Hong Kong 112
SG - Singapore 104
UA - Ucraina 95
DE - Germania 73
CN - Cina 45
FI - Finlandia 41
AU - Australia 25
GB - Regno Unito 25
IN - India 21
JO - Giordania 21
TR - Turchia 12
FR - Francia 9
VN - Vietnam 8
BE - Belgio 5
CI - Costa d'Avorio 5
ID - Indonesia 5
BR - Brasile 3
CH - Svizzera 3
JP - Giappone 3
AE - Emirati Arabi Uniti 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
Totale 4.835
Città #
Santa Clara 758
Warsaw 526
Chandler 240
Fairfield 229
Jacksonville 176
Dublin 168
Ashburn 135
Seattle 115
Cambridge 110
Woodbridge 104
Singapore 91
Wilmington 81
Houston 76
Hong Kong 72
Boardman 42
Princeton 39
Boston 24
Melbourne 24
Altamura 23
Ann Arbor 22
Lawrence 22
Medford 21
San Diego 21
Kent 18
Buffalo 17
Mumbai 17
New York 13
Beijing 11
Shanghai 11
Izmir 10
Milan 10
Florence 9
Moscow 9
Capaccio 8
Bologna 7
Frankfurt Am Main 7
Los Angeles 7
Yubileyny 7
Abidjan 5
Brussels 5
Duncan 5
Jakarta 5
Laurel 5
Norwalk 5
Pisa 5
Auburn Hills 4
Arezzo 3
Bern 3
London 3
Minamiuebaru 3
Phoenix 3
Pune 3
Verona 3
Andover 2
Falls Church 2
Helsinki 2
Hillsboro 2
Naples 2
Orenburg 2
Rome 2
San Mateo 2
Segrate 2
Tappahannock 2
West Jordan 2
Acate 1
Acton 1
Anzio 1
Bagno a Ripoli 1
Barcelona 1
Berlin 1
Bitritto 1
Brisbane 1
Cachoeirinha 1
Council Bluffs 1
Dubai 1
Frankfurt am Main 1
Huizhou 1
Kilburn 1
Ma'anshan 1
Munich 1
Nanchang 1
Nanyang 1
Oslo 1
Ottawa 1
Qingdao 1
Redwood City 1
Salerno 1
Seoul 1
Shenzhen 1
Southend 1
Stockholm 1
São José dos Campos 1
São Paulo 1
Thrissur 1
Wuhan 1
Totale 3.393
Nome #
Evidence for oxidative stress in plasma of patients with Marfan syndrome 265
High prevalence in ACE DD and genotype in patients with atrial fibrillation 240
Vascular and connective tissue features in 5 italian patients with homocystinuria 238
May TGFBR1 act also as low penetrance ellele in marfan syndrome? 204
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. 146
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 142
Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome 134
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients 130
Electrophysiologic procedures and activation of the hemostatic system 125
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients 123
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. 118
Multicenter experience with implantable defibrillators subject to recall. 117
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 116
Diastolic subclinical primary alterations in Marfan syndrome and Marfan related disorders 115
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 115
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. 114
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 113
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 113
Dual-site left ventricular cardiac resynchronization therapy. 111
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation 110
Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy 107
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis. 104
Phenotypic variability of cardiovascularmanifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia andC677T MTHFR gene polymorphism. 103
Bioavailability of digoxin-hydroquinone complex 102
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 101
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. 97
A major involvment of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. 95
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements 95
Marfan's syndrome. Clinical and molecular characterization of 51 italian patients 92
Prognostic value of Doppler-derived mitral deceleration time on left ventricular reverse remodelling after undersized mitral annuloplasty 84
Wavelenght index at three atrial sites in patients with peroxysmal atrial fibrillation 83
Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. 82
Persistent subendocardial ischemia after hyperventilation 82
New therapeutic strategies in heart failure. Which patients need defibrillation backup? 76
Thoracic aortic aneurysm. New evidence for fibrillin-1 involvement 74
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation 71
Temporal Variation in Optimal Atrioventricular and Interventricular Delay During Cardiac Resynchronization Therapy 70
Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch 70
Paroxysmal atrial fibrillation: epidemiology and clinical relevance 67
Prevalence of cardiovascular manifestations in Marfan syndrome 67
Rotational mechanics of the left ventricle in AL amyloidosis 64
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 62
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 61
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure 61
Totale 4.859
Categoria #
all - tutte 12.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020296 0 0 0 0 0 0 58 88 54 31 58 7
2020/2021439 40 31 39 48 10 57 15 46 31 59 16 47
2021/2022238 6 26 6 12 15 9 7 13 10 15 52 67
2022/2023789 66 116 28 89 58 149 113 55 73 3 24 15
2023/2024316 20 33 48 26 13 45 13 76 3 3 28 8
2024/20251.666 61 199 149 334 638 279 6 0 0 0 0 0
Totale 4.859